Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

L. Mega, Jessica; Braunwald, Eugene; D. Wiviott, Stephen; Bassand, Jean‐Pierre; L. Bhatt, Deepak; Bode, Christoph; Burton, Paul; Cohen, Marc; Cook‐Bruns, Nancy; A.A. Fox, Keith; Goto, Shinya; A. Murphy, Sabina; N. Plotnikov, Alexei; J. Schneider, David; Sun, Xiang; W.A. Verheugt, Freek; Michael Gibson, C.

doi:10.1056/nejmoa1112277

Public

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

Published in New England Journal of Medicine • Nov 13, 2011

Authors:

Jessica L. Mega

Eugene Braunwald

Stephen D. Wiviott

Abstract

BACKGROUND: Acute coronary syndromes arise from coronary atherosclerosis with superimposed thrombosis. Since factor Xa plays a central role in thrombosis, the inhibition of factor Xa with low-dose rivaroxaban might improve cardiovascular outcomes in patients with a recent acute coronary syndrome. ME...

Subject

Rivaroxaban

Acute coronary syndrome

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!